Hematology drugs market offers drugs, blood and blood products
that are used for the treatment of diseases such as rare genetic disorders,
anemia, and conditions related to sickle cell disease and other related
diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex,
and Hyskon.
Read the
report at
The substantial growth of the market from $40 billion in 2017 to around
$52 billion by 2021 is due to the unhealthy lifestyle of consumers leading to
anemia and coagulation disorders. Factors such as increased longevity and the
launch of pipeline drugs will also drive the market for hematology drugs.
In the report, the hematology drugs market is divided into blood
products and anemia and other blood disorder drugs, with blood products
occupying the major market share (nearly 70%) and remaining is occupied by
anemia and other blood products.
Download a
sample of the report at
The USA was the largest country in the
hematology drugs market in 2017, accounting for 30% of the market share. This
was mainly due to high drug prices and high healthcare spending in the USA
compared to other countries. China and Brazil followed the USA as the next largest countries
in the market.
The hematology drugs market is fragmented with a number of large
and small organizations. The top five competitors in the market made up around 25%
of the total market in 2017. Novo Nordisk A/S was the largest competitor
followed by Shire Plc., Bayer AG, Daiichi Sankyo Company Limited and Biogen
Inc. Novo Nordisk A/S is a healthcare company involved in discovering,
developing, manufacturing, and marketing of pharmaceutical products. Novo
Nordisk markets and distributes its products through distributors and independent
agents worldwide.
About The
Business Research Company.
The Business Research Company is a Business Intelligence Company
which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
15 countries globally.
Contact
Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
No comments:
Post a Comment